Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulse Biosciences (PLSE) Non-cash Items (2020 - 2025)

Pulse Biosciences (PLSE) has 6 years of Non-cash Items data on record, last reported at $5.1 million in Q4 2025.

  • For Q4 2025, Non-cash Items fell 94.77% year-over-year to $5.1 million; the TTM value through Dec 2025 reached $5.1 million, down 94.77%, while the annual FY2025 figure was $5.1 million, 94.77% down from the prior year.
  • Non-cash Items reached $5.1 million in Q4 2025 per PLSE's latest filing, up from $4.8 million in the prior quarter.
  • Across five years, Non-cash Items topped out at $97.6 million in Q4 2024 and bottomed at $208189.0 in Q1 2023.
  • Average Non-cash Items over 5 years is $8.7 million, with a median of $3.4 million recorded in 2022.
  • Peak YoY movement for Non-cash Items: tumbled 98.42% in 2022, then skyrocketed 2444.9% in 2024.
  • A 5-year view of Non-cash Items shows it stood at $15.8 million in 2021, then crashed by 98.42% to $248861.0 in 2022, then surged by 1440.48% to $3.8 million in 2023, then surged by 2444.9% to $97.6 million in 2024, then plummeted by 94.77% to $5.1 million in 2025.
  • Per Business Quant database, its latest 3 readings for Non-cash Items were $5.1 million in Q4 2025, $4.8 million in Q3 2025, and $4.6 million in Q2 2025.